Want to join the conversation?
In 2Q16, $FTR had Capex of $350MM and the company spent an additional $36MM related to integration activities. Adjusted free cash flow was $250MM. The BoD declared a common dividend of $0.105 per share for 3Q16, payable September 30, 2016. $FTR ended 2Q16 with approx. $1.4Bil in cash and credit availability.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?